SOCS2 inhibits the tumorigenesis of GISTs and increases the sensitivity of GISTs to imatinib by suppression of KIT activationLiangying Zhang, Jianmin Sun|Scientific Reports|2025Cited by 2
Entry of ZSWIM4 to the nucleus is crucial for its inhibition of KIT and BMAL1 in gastrointestinal stromal tumorsXu Cao, Jianmin Sun|Cell & Bioscience|2024Cited by 1